Are you a highly motivated and independent professional with a passion for innovation? We’re seeking an R&D Engineer to join our dynamic team at Selux. As an R&D Engineer, you’ll collaborate with a multidisciplinary group of experts, including microbiologists, chemists, mechanical engineers (MEs), electrical engineers (EEs), and software engineers. Your mission: to drive the development, improvement, and verification of Selux products while ensuring compliance with quality standards and regulatory requirements. You will report to the Director of Systems & Test Engineering. As this role is primarily hands on, you will be expected to be in the Charlestown, MA office most days, however there may be up to 10% travel requested.
- Collaborate with a team to develop Class II IVD systems for the Infectious Disease market.
- Conduct troubleshooting and failure analysis both independently as well as with support from external consultants.
- Develop and test prototypes, conducting experiments to verify concepts and refine designs.
- Serve as a technical resource for Field Service organization.
- Identify areas for product improvement and execute design changes.
- Author and execute test plans and reports to support ongoing design verification.
- Other duties as assigned.
- BS degree in Mechanical or Biomedical Engineering with 3-5 years working in medical device development.
- Demonstrated problem solving ability and techniques and able to clearly explain technical ideas and concepts.
- Experience working in biological or chemistry labs a plus.
- Experience writing procedures for others to follow.
- Must be a self-starter, able to work independently, willing to take initiative and demonstrate efficient and effective time management.
- Excellent written and oral communication skills and a proven ability to work well on a multidisciplinary team of scientists and engineers.
Target Salary Range: $110K-$135K. Compensation to be determined based on experience.
Antibiotics are lifesaving drugs, but rapidly emerging antimicrobial resistance is threatening that reality. Selux’s mission is to preserve the lifesaving efficacy of antibiotics by providing diagnostic results in hours, rather than days, and we are building a multidisciplinary team of talented individuals to help achieve this mission.
Joining the Selux team will give you an opportunity to harness your talent and advance your career by working in diverse groups of high-performing teammates tackling the most important healthcare challenges.
The customers and patients we serve have diverse life experiences and so do we. Selux is focused on hiring talented people from a wide range of backgrounds and providing an environment where everyone feels that they belong. We offer a competitive benefits package including healthcare, 401K match, stock option grants, open paid time off and supportive family leave policies.
Selux Diagnostics is proud to be an inclusive workplace and an Equal Opportunity Employer.
We believe every member of the Selux team is an essential contributor to our vision of preserving the lifesaving power of antibiotics and that our strength lies not only in what we do, but how we do it. These values represent the way that Seluxors approach their work. If you're someone who is relentless, collaborative, and adaptable, Selux might be just the place for you!
- We know that every second counts for patients and we are dedicated to saving lives and fighting antimicrobial resistance.
- We’re people people through and through. We love to work and play together and believe we are capable of more when we join forces as a community.
- The only way to achieve our goals is by staying flexible and positive when faced with uncertainty. We see challenges as opportunities to grow.
Top Skills
What We Do
Selux Diagnostics is developing a Next Generation Phenotyping (NGP) platform that promises to transform infectious disease patient treatment by dramatically increasing the speed and accuracy with which targeted, personalized antibiotic therapies can be prescribed. Earlier, better-informed treatment decisions will save lives, improve patient outcomes, decrease hospital lengths of stay and hospital acquired infections, and help combat the global antibiotic resistance epidemic.
The CDC has cited bacterial resistance to antibiotics among the world’s deadliest and costliest health threats. Using current technologies, doctors must overprescribe powerful, broad-spectrum antibiotics for days while waiting for key diagnostic results to direct personalized therapy. SeLux NGP is the only platform capable of delivering personalized therapy results for all patients within a day of hospital entry, speeding this targeted treatment by an average of 2 days and as many as 4 days for patients infected with multi-drug resistant organisms.
Selux Diagnostics was founded in 2014 by two Yale- and Harvard-trained engineers working in an improvised attic laboratory.
On September 25, 2018, SeLux announced that it had signed a milestone-based contract worth up to $45 million with BARDA, a division of the U.S. Department of Health and Human Services’ (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR). SeLux immediately receives $9.3 million from BARDA to fund the clinical trial necessary for SeLux NGP, SeLux's next-generation phenotyping platform. The additional $36 million will fund the development of SeLux's second-generation rapid sepsis diagnostic system.
SeLux has also raised $25 million in Series B financing to support the pivotal FDA trial for SeLux’s NGP platform. The round was led by Sands Capital Ventures and included returning investors RA Capital and Schooner Capital and new investors Sands Capital and Northpond Ventures.
